We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Biological Functions and Therapeutic Potential of NAD + Metabolism in Gynecological Cancers.
- Authors
Myong, Subin; Nguyen, Anh Quynh; Challa, Sridevi
- Abstract
Simple Summary: NAD+ is a key cofactor that plays a role in various metabolic and signaling pathways. Understanding its ability to regulate cellular homeostasis also sheds light on its role in tumorigenesis and disease progression in gynecologic cancers. By reviewing the enzymes that consume NAD+ as well as the pathways and enzymes that synthesize NAD+, the vast influence NAD+ has on the survival of cancer cells becomes clear. With that information, advances have been made in the development of unique inhibitors to target NAD+ synthesizing and consuming enzymes. Nicotinamide adenine dinucleotide (NAD+) is an important cofactor for both metabolic and signaling pathways, with the dysregulation of NAD+ levels acting as a driver for diseases such as neurodegeneration, cancers, and metabolic diseases. NAD+ plays an essential role in regulating the growth and progression of cancers by controlling important cellular processes including metabolism, transcription, and translation. NAD+ regulates several metabolic pathways such as glycolysis, the citric acid (TCA) cycle, oxidative phosphorylation, and fatty acid oxidation by acting as a cofactor for redox reactions. Additionally, NAD+ acts as a cofactor for ADP-ribosyl transferases and sirtuins, as well as regulating cellular ADP-ribosylation and deacetylation levels, respectively. The cleavage of NAD+ by CD38—an NAD+ hydrolase expressed on immune cells—produces the immunosuppressive metabolite adenosine. As a result, metabolizing and maintaining NAD+ levels remain crucial for the function of various cells found in the tumor microenvironment, hence its critical role in tissue homeostasis. The NAD+ levels in cells are maintained by a balance between NAD+ biosynthesis and consumption, with synthesis being controlled by the Preiss–Handler, de novo, and NAD+ salvage pathways. The primary source of NAD+ synthesis in a variety of cell types is directed by the expression of the enzymes central to the three biosynthesis pathways. In this review, we describe the role of NAD+ metabolism and its synthesizing and consuming enzymes' control of cancer cell growth and immune responses in gynecologic cancers. Additionally, we review the ongoing efforts to therapeutically target the enzymes critical for NAD+ homeostasis in gynecologic cancers.
- Subjects
METABOLIC disorders; OXIDATION-reduction reaction; HOMEOSTASIS; GLYCOLYSIS; PHOSPHORYLATION; IMMUNOSUPPRESSIVE agents; ADENOSINES; TUMOR markers; NEURODEGENERATION; CELLULAR signal transduction; FEMALE reproductive organ tumors; ENERGY metabolism; FATTY acids; TRANSFERASES; COENZYMES; METABOLISM
- Publication
Cancers, 2024, Vol 16, Issue 17, p3085
- ISSN
2072-6694
- Publication type
Article
- DOI
10.3390/cancers16173085